CVS Health Corporation (CVS) : During the past 4 weeks, traders have been relatively bearish on CVS Health Corporation (CVS), hence the stock is down -1.91% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.12% relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.36% in the last 1 week, and is up 2.37% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock. The stock has recorded a 20-day Moving Average of 2.1% and the 50-Day Moving Average is 0.82%.
CVS Health Corporation (NYSE:CVS): The stock opened at $97.95 on Friday but the bulls could not build on the opening and the stock topped out at $97.95 for the day. The stock traded down to $96.91 during the day, due to lack of any buying support eventually closed down at $97.09 with a loss of -0.38% for the day. The stock had closed at $97.46 on the previous day. The total traded volume was 3,346,208 shares.
The company Insiders own 0.58% of CVS Health Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -9.75% . Institutional Investors own 85.22% of CVS Health Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -20.69%. In a related news,The director officer (President and CEO) of Cvs Health Corp, Merlo Larry J sold 38,247 shares at $105 on May 5, 2016. The Insider selling transaction had a total value worth of $4,015,935. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.